FILE:HUM/HUM-8K-20120912172655.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
 
           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
 
          Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
 
         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
 
         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
 
 
Item 8.01   Other Events.
In its quarterly report on Form 10-Q for the quarter ended June 30, 2012, Humana Inc. (the Company) disclosed that all material contracts between Humana and CMS relating to the companys Medicare business had been renewed for 2013.  The Company is now reporting that all of its 2013 Medicare Advantage (MA) and Prescription Drug Plan (PDP) offerings filed with The Centers for Medicare and Medicaid Services (CMS) in June 2012 have been approved by CMS and the related contracts have been executed (referred to as the CMS Contracts).
Humana will offer the following MA and PDP plans for its Medicare members effective beginning January 1, 2013:
 
 
 
 
The marketing process for the Companys 2013 Medicare offerings begins on October 1, 2012, with enrollment beginning October 15, 2012.
Each of the CMS Contracts was effective when signed, has a termination date of December 31, 2013 and may be renewed for successive one-year terms subject to the consent of the parties and their agreement on a bid as submitted by Humana or its subsidiaries. Each of the CMS Contracts may be terminated by either party in the event of the failure by the other to substantially carry out its obligations under the CMS Contracts, and by CMS in the event of a violation by Humana of relevant CMS regulations.
 
 
 
 
 
 
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
Dated:           September 12, 2012


